The current state of bariatric endoscopy

Thomas R. McCarty; Christopher C. Thompson

doi:10.1111/den.13698

The current state of bariatric endoscopy

Thomas R. McCarty, Christopher C. Thompson

Research output: Contribution to journal › Review article › peer-review

19 Scopus citations

Abstract

A variety of endoscopic bariatric and metabolic treatments (EBMTs) have been developed in recent years to combat the growing prevalence of obesity in the United States (US) and worldwide. This manuscript reviews the current state of bariatric endoscopy, detailing all US Food and Drug Administration (FDA) approved EBMTs including space-occupying intragastric balloons (IGBs), aspiration therapy, and endoscopic tissue apposition devices. Additionally, this review describes non-FDA approved treatments including additional IGBs, endoluminal bypass liners, duodenal mucosal resurfacing, and endoscopically placed anastomosis devices.

Original language	English (US)
Pages (from-to)	321-334
Number of pages	14
Journal	Digestive Endoscopy
Volume	33
Issue number	3
DOIs	https://doi.org/10.1111/den.13698
State	Published - Mar 2021

Keywords

bariatric endoscopy
endoscopic bariatric and metabolic treatments (EBMTs)
obesity
weight loss

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Gastroenterology

Access to Document

10.1111/den.13698

Cite this

@article{44a56d050ea44ac9b32f7924c11c229f,

title = "The current state of bariatric endoscopy",

abstract = "A variety of endoscopic bariatric and metabolic treatments (EBMTs) have been developed in recent years to combat the growing prevalence of obesity in the United States (US) and worldwide. This manuscript reviews the current state of bariatric endoscopy, detailing all US Food and Drug Administration (FDA) approved EBMTs including space-occupying intragastric balloons (IGBs), aspiration therapy, and endoscopic tissue apposition devices. Additionally, this review describes non-FDA approved treatments including additional IGBs, endoluminal bypass liners, duodenal mucosal resurfacing, and endoscopically placed anastomosis devices.",

keywords = "bariatric endoscopy, endoscopic bariatric and metabolic treatments (EBMTs), obesity, weight loss",

author = "McCarty, {Thomas R.} and Thompson, {Christopher C.}",

note = "Publisher Copyright: {\textcopyright} 2020 Japan Gastroenterological Endoscopy Society",

year = "2021",

month = mar,

doi = "10.1111/den.13698",

language = "English (US)",

volume = "33",

pages = "321--334",

journal = "Digestive Endoscopy",

issn = "0915-5635",

publisher = "Wiley",

number = "3",

}

TY - JOUR

T1 - The current state of bariatric endoscopy

AU - McCarty, Thomas R.

AU - Thompson, Christopher C.

PY - 2021/3

Y1 - 2021/3

N2 - A variety of endoscopic bariatric and metabolic treatments (EBMTs) have been developed in recent years to combat the growing prevalence of obesity in the United States (US) and worldwide. This manuscript reviews the current state of bariatric endoscopy, detailing all US Food and Drug Administration (FDA) approved EBMTs including space-occupying intragastric balloons (IGBs), aspiration therapy, and endoscopic tissue apposition devices. Additionally, this review describes non-FDA approved treatments including additional IGBs, endoluminal bypass liners, duodenal mucosal resurfacing, and endoscopically placed anastomosis devices.

AB - A variety of endoscopic bariatric and metabolic treatments (EBMTs) have been developed in recent years to combat the growing prevalence of obesity in the United States (US) and worldwide. This manuscript reviews the current state of bariatric endoscopy, detailing all US Food and Drug Administration (FDA) approved EBMTs including space-occupying intragastric balloons (IGBs), aspiration therapy, and endoscopic tissue apposition devices. Additionally, this review describes non-FDA approved treatments including additional IGBs, endoluminal bypass liners, duodenal mucosal resurfacing, and endoscopically placed anastomosis devices.

KW - bariatric endoscopy

KW - endoscopic bariatric and metabolic treatments (EBMTs)

KW - obesity

KW - weight loss

UR - http://www.scopus.com/inward/record.url?scp=85094176790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85094176790&partnerID=8YFLogxK

U2 - 10.1111/den.13698

DO - 10.1111/den.13698

M3 - Review article

C2 - 32301158

AN - SCOPUS:85094176790

SN - 0915-5635

VL - 33

SP - 321

EP - 334

JO - Digestive Endoscopy

JF - Digestive Endoscopy

IS - 3

ER -

The current state of bariatric endoscopy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this